Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Net Income: 2013-2024

Historic Net Income for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to -$22.7 million.

  • vTv Therapeutics' Net Income fell 77.14% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.4 million, marking a year-over-year decrease of 24.97%. This contributed to the annual value of -$22.7 million for FY2024, which is 12.56% up from last year.
  • Per vTv Therapeutics' latest filing, its Net Income stood at -$22.7 million for FY2024, which was up 12.56% from -$26.0 million recorded in FY2023.
  • Over the past 5 years, vTv Therapeutics' Net Income peaked at -$12.8 million during FY2020, and registered a low of -$26.0 million during FY2023.
  • For the 3-year period, vTv Therapeutics' Net Income averaged around -$24.6 million, with its median value being -$25.1 million (2022).
  • As far as peak fluctuations go, vTv Therapeutics' Net Income spiked by 41.64% in 2020, and later slumped by 41.41% in 2022.
  • Over the past 5 years, vTv Therapeutics' Net Income (Yearly) stood at -$12.8 million in 2020, then slumped by 38.50% to -$17.7 million in 2021, then tumbled by 41.41% to -$25.1 million in 2022, then declined by 3.56% to -$26.0 million in 2023, then grew by 12.56% to -$22.7 million in 2024.